Press Release Jul 06 2022

We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Triamcinolone Acetonide Injectable Suspension.

View Attachment